Structural understanding of stabilization patterns in engineered bispecific Ig-like antibody molecules
- PMID: 19626705
- DOI: 10.1002/prot.22502
Structural understanding of stabilization patterns in engineered bispecific Ig-like antibody molecules
Abstract
Bispecific immunoglobulin-like antibodies capable of engaging multiple antigens represent a promising new class of therapeutic agents. Engineering of these molecules requires optimization of the molecular properties of one of the domain components. Here, we present a detailed crystallographic and computational characterization of the stabilization patterns in the lymphotoxin-beta receptor (LTbetaR) binding Fv domain of an anti-LTbetaR/anti-TNF-related apoptosis inducing ligand receptor-2 (TRAIL-R2) bispecific immunoglobulin-like antibody. We further describe a new hierarchical structure-guided approach toward engineering of antibody-like molecules to enhance their thermal and chemical stability.
2009 Wiley-Liss, Inc.
Similar articles
-
Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR.MAbs. 2009 Mar-Apr;1(2):128-41. doi: 10.4161/mabs.1.2.7631. Epub 2009 Mar 11. MAbs. 2009. PMID: 20061822 Free PMC article.
-
Stability engineering of scFvs for the development of bispecific and multivalent antibodies.Protein Eng Des Sel. 2010 Jul;23(7):549-57. doi: 10.1093/protein/gzq028. Epub 2010 May 10. Protein Eng Des Sel. 2010. PMID: 20457695
-
Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies.Protein Eng Des Sel. 2011 May;24(5):447-54. doi: 10.1093/protein/gzq123. Protein Eng Des Sel. 2011. PMID: 21498564
-
Antibody therapeutics, antibody engineering, and the merits of protein stability.Curr Opin Drug Discov Devel. 2008 Sep;11(5):675-87. Curr Opin Drug Discov Devel. 2008. PMID: 18729019 Review.
-
Diabodies: molecular engineering and therapeutic applications.Drug News Perspect. 2009 Oct;22(8):453-8. Drug News Perspect. 2009. PMID: 20016854 Review.
Cited by
-
Solubility, Stability, and Avidity of Recombinant Antibody Fragments Expressed in Microorganisms.Front Microbiol. 2020 Sep 25;11:1927. doi: 10.3389/fmicb.2020.01927. eCollection 2020. Front Microbiol. 2020. PMID: 33101218 Free PMC article. Review.
-
Rapid optimization and prototyping for therapeutic antibody-like molecules.MAbs. 2013 Mar-Apr;5(2):237-54. doi: 10.4161/mabs.23363. Epub 2013 Feb 7. MAbs. 2013. PMID: 23392215 Free PMC article.
-
Redistribution of flexibility in stabilizing antibody fragment mutants follows Le Châtelier's principle.PLoS One. 2014 Mar 26;9(3):e92870. doi: 10.1371/journal.pone.0092870. eCollection 2014. PLoS One. 2014. PMID: 24671209 Free PMC article.
-
Advances in Antibody Design.Annu Rev Biomed Eng. 2015;17:191-216. doi: 10.1146/annurev-bioeng-071114-040733. Epub 2015 Aug 14. Annu Rev Biomed Eng. 2015. PMID: 26274600 Free PMC article. Review.
-
Optimization of an Antibody Light Chain Framework Enhances Expression, Biophysical Properties and Pharmacokinetics.Antibodies (Basel). 2019 Sep 6;8(3):46. doi: 10.3390/antib8030046. Antibodies (Basel). 2019. PMID: 31544852 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources